Economic Sustainability of Trifluridine/Tipiracil for the Treatment of Refractory Metastatic Colorectal Cancer in Real Life

Volume: 19, Issue: 4, Pages: e181 - e182
Published: Dec 1, 2020
Abstract
Bullement et al 1 Bullement A. Underhill S. Fougeray R. Hatswell A.J. Cost-effectiveness of trifluridine/tipiracil for previously treated metastatic colorectal cancer in England and Wales. Clin Colorectal Cancer. 2018; 17: 143-151 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar recently investigated the cost-effectiveness of trifluridine/tipiracil in patients with metastatic colorectal cancer (mCRC) who had been previously...
Paper Details
Title
Economic Sustainability of Trifluridine/Tipiracil for the Treatment of Refractory Metastatic Colorectal Cancer in Real Life
Published Date
Dec 1, 2020
Volume
19
Issue
4
Pages
e181 - e182
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.